Independent Evaluations of RapidChek® E. coli O157
Strategic Diagnostics, Inc. announced the completion of evaluations performed by major independent laboratories on SDI's RapidChek® test for E. coli O157. The results from these evaluations have prompted a globally recognized laboratory corporation to begin a nationwide implementation of the RapidChek® E. coli O157 test method into its testing protocols. This corporation expects its implementation to be complete by March 2003 and to impact many of its laboratories in the United States.
In another major development, a leading global foodservice provider has completed an in-depth study of the RapidChek® E. coli O157 test. According to statements made by the foodservice provider, the findings of this study revealed that laboratories performing the RapidChek® test found a 65% reduction in overall false positives when compared to a well-recognized competitive test, and that RapidChek® showed greater sensitivity and was easier to use than the competitive brand. This foodservice provider has endorsed the use by its meat suppliers of RapidChek® tests for their E. coli O157 testing needs. Several of these suppliers initiated use of RapidChek® in January.
Another significant evaluation performed by a U.S. regulatory agency has shown that the RapidChek® E. coli O157 media performs better than other commonly used media.
In other news, the Company announced the commercial launch of a pathogen test to detect salmonella. Salmonella is the most common food pathogen and is found in a wide variety of foods including meats, dairy products and processed foods. SDI believes that its new test has several advantages over competitive methods, including a simplified preparation process that makes the test easier to run versus competitive brands. The product's performance standard meets all necessary regulatory requirements. Plans are currently underway for key evaluations with major food companies and laboratories.
Commenting on this news, Richard Birkmeyer, President and CEO said We are delighted to have earned such favorable reports on our E. coli O157 tests and are excited about the launch of our new salmonella test. The global market for salmonella tests exceeds $100 million. Changes in USDA regulations have increased the amount of mandatory E. coli O157 testing. These changes have resulted in the majority of industry sampling plans being modified in a way that is expected to yield a two-to-four times increase in E. coli O157 testing. We expect to attract a meaningful share of the food pathogen testing market in 2003.
Source: Strategic Diagnostics Inc. [USA]
Now part of Romer Labs, Inc. View company information
Posted: February 7, 2003
[will open your email client]